RNAZ Transcode Therapeutics, Inc.

Nasdaq transcodetherapeutics.com


$ 9.20 $ 0.08 (0.86 %)    

Tuesday, 11-Nov-2025 10:58:34 EST
QQQ $ 618.77 $ -1.84 (-0.3 %)
DIA $ 475.80 $ 1.59 (0.34 %)
SPY $ 679.75 $ -0.23 (-0.03 %)
TLT $ 90.04 $ 0.10 (0.11 %)
GLD $ 378.24 $ -1.79 (-0.47 %)
$ 9.4
$ 9.35
$ 8.96 x 100
$ 9.27 x 141
$ 9.35 - $ 9.35
$ 6.15 - $ 468.44
13,839
na
7.84M
$ -45,477.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 transcode-achieves-phase-1a-safety-milestone-for-ttx-mc138-advancing-to-phase-2a-after-durability-and-disease-control-in-cancer-patients

Safety primary endpoint achievedMedian treatment duration of 4 months with a range of 2 to 12 months and three patients remain ...

 transcode-makes-bold-bet-on-melanoma-vaccine-with-polynoma-buyout

TransCode Therapeutics Inc. (NASDAQ: RNAZ) to acquire Polynoma LLC and receive $25 million investment from CK Life Sciences.

 transcode-therapeutics-signs-agreement-to-acquire-polynoma-for-20m-cash-5m-promissory-note

BOSTON and SAN DIEGO, Oct. 8, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Comp...

 reported-may-14-2025-transcode-therapeutics-q1-eps-251-misses-200-estimate

TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate...

 us-stocks-likely-to-open-lower-after-sp-500s-9-day-streak-any-de-escalation-in-trade-tensions-should-be-positive-says-expert

U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Futures of benchmark indices were l...

 transcode-therapeutics-announces-1-for-28-reverse-stock-split-the-effective-date-of-the-reverse-stock-split-has-not-yet-been-determined

Split designed to achieve compliance with Nasdaq minimum bid price requirementsBOSTON, May 2, 2025 /PRNewswire/ -- TransCode Th...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION